Because some metabolic intermediates are involved in more than one pathway, crosstalk between pathways is crucial to maintaining homeostasis. AMP and histidine biosynthesis pathways are coregulated at the transcriptional level in response to adenine availability. 5Ј-Phosphoribosyl-4-carboxamide-5-aminoimidazole (AICAR), a metabolic intermediate at the crossroads between these two pathways, is shown here to be critical for activation of the transcriptional response in the absence of adenine. In this study, we show that both AMP and histidine pathways significantly contribute to AICAR synthesis. Furthermore, we show that upregulation of the histidine pathway clearly interferes with regulation of the AMP pathway, thus providing an explanation for the regulatory crosstalk between these pathways. Finally, we revisit the histidine auxotrophy of ade3 or ade16 ade17 mutants. Interestingly, overexpression of PMU1, encoding a potential phosphomutase, partially suppresses the histidine requirement of an ade3 ade16 ade17 triple mutant, most probably by reducing the level of AICAR in this mutant. Together our data clearly establish that AICAR is not just a metabolic intermediate but also acts as a true regulatory molecule.
M ETABOLIC pathways generate multiple meta-
While we clearly established a role for SAICAR in ADE pathway regulation, the role of 5Ј-phosphoribosyl-4-carbolic intermediates, which contribute widely to intracellular chemical diversity. Evolution has taken adboxamide-5-aminoimidazole (AICAR) in this regulatory process remained obscure. Unlike SAICAR, which is vantage of this diversity and several of these small molecules have been shown to play a crucial and direct role produced only through the IMP pathway, AICAR not only is produced by Ade13p in the IMP pathway, but in regulation of gene expression (Sze et al. 1992; Feller et al. 1994; Flynn and Reece 1999; Loewen et al. 2004) .
also is a by-product of histidine biosynthesis ( Figure 1 ). Interestingly, in yeast it has been shown that histidine On the basis of genetics studies in budding yeast, and AMP biosynthesis pathways are coregulated (Daigour previous work has revealed that 5Ј-phosphoribosylnan-Fornier and Fink 1992); i.e., expression of HIS1, 4-succinocarboxamide-5-aminoimidazole (SAICAR), an HIS4, and HIS7 ( Figure 1 ) is activated by Bas1p and intermediate metabolite of purine biosynthesis, is critiBas2p and repressed by extracellular adenine (Arndt cal for the expression of AMP biosynthesis genes (ADE et al. 1987; Springer et al. 1996; Denis et al. 1998) . In genes) in the absence of an extracellular purine source Aspergillus nidulans, expression of the hisHF gene (the (Rébora et al. 2001) . We found that mutations affecting equivalent of the HIS7 gene in Saccharomyces cerevisiae) the first seven steps of the IMP biosynthesis pathway is also regulated by adenine (Valerius et al. 2001) . (Figure 1 ) result in permanent repression of ADE1-lacZ
The physiological raison d'être of such a cross-pathway expression, whereas mutations affecting the last three regulation is still unclear. steps (ade13 or ade16 ade17) result in a constitutive dereIntriguingly, ade3 and ade16 ade17 mutant strains are pression of ADE1 expression. Study of ADE1 expression auxotrophic for both adenine and histidine, a phenoin an ade2 ade13 double-mutant strain revealed that ade2 type also reported for Schizosaccharomyces pombe equivais epistatic to ade13, thus confirming the essential role lent mutants, ade9 and ade10, respectively (Whitehead of SAICAR in the activation of ADE gene expression et al. 1966) . ADE3 encodes a trifunctional enzyme cata- (Rébora et al. 2001) . At the molecular level, we have lyzing three reactions that lead to the synthesis of 10-shown that SAICAR activates ADE gene expression by formyl tetrahydrofolate (THF), a cosubstrate required promoting interaction between Bas1p and Bas2p, two for the third and the ninth steps of IMP biosynthesis transcription factors required for ADE gene expression ( Figure 1 ). Since 5,10-methylene THF, which accumu- (Rébora et al. 2001) .
lates in the ade3 mutant, inhibits the fourth enzyme of histidine biosynthesis in vitro, it was proposed that this inhibition could lead to histidine auxotrophy in vivo 1 coregulation. Finally, we have identified a multicopy suppressor of the histidine auxotrophy of an ade3 ade16 ade17 triple mutant and have documented the toxicity of AICAR and SAICAR accumulation in yeast cells.
MATERIALS AND METHODS
Yeast strains and media: Yeast strains are listed in Table  1 . All double-mutant strains constructed in this work were obtained by mating single knockout mutant strains (purchased from EUROSCARF) isogenic to BY4742 (Brachmann et al. 1998) . Triple mutants were obtained by mating two isogenic double mutants (except for ade2 ade3 ade13 ; see below).
ade3 ade2 ade13 triple mutants were obtained by mating Y1261 (ade2 ade13) and Y16591 (ade3) strains. After sporulation of the resulting diploids, tetrads were dissected and the genotype of the four spores of each tetrad was analyzed. ade3 spores were identified by their geneticine resistance phenotype. To identify ade2 spores, the four spores of each tetrad were mated with a or ␣ ade2 strains. Auxotrophy for adenine and red or white color of the diploid was tested to determine which spores were ade2. To identify ade13 spores, the four Figure 1 .-Schematic of histidine and IMP biosynthesis spores of each tetrad were mated with a or ␣ ade13 strains. pathways and reactions supplying 10 formyl-THF for IMP bioExpression of the ADE1-lacZ fusion was monitored in the resynthesis. FGAR, 5Ј-phosphoribosyl N-formylglycinamide; IMP, sulting diploids by ␤-galactosidase (␤-gal) assays to determine inosine 5Ј-monophosphate; PRPP, 5-phosphoribosyl-1-pyrophoswhich diploids have a bra phenotype (Guetsova et al. 1997 et al. (1986) . SD casa medium is SD supplemented cated.
with 0.2% (w/v) casaminoacids (DIFCO). Screening for multicopy suppressors of ade3 ade16 ade17 histidine auxotrophy: Strain Y2406 was transformed with a phic for histidine (Tibbetts and Appling 2000) does multicopy library (kind gift from F. Lacroute). Transformants not fit well with this hypothesis, especially since an ade8 ‫)000,31ف(‬ were grown and replica plated on medium lacking histidine. Colonies able to grow in the absence of histidine mutant, which is affected in the other 10-formyl-THFwere selected, and plasmid DNA was extracted. Plasmids able consuming step of the IMP pathway, is prototrophic for to suppress histidine auxotrophy were isolated and the insert histidine. We therefore favor the recent hypothesis of boundaries were sequenced.
Appling and co-workers who propose that the auxotroPlasmids: P1933 (Rébora et al. 2001 ) is a URA3 centromeric phy for histidine is likely linked to accumulation of plasmid expressing ADE4 under control of a tetracycline regulatable promoter (Gari et al. 1997) . P2122 is a tet-ADE4 LEU2 AICAR, rather than to accumulation of 5,10-methylene centromeric plasmid obtained by swapping the P1933 marker THF (Tibbetts and Appling 2000) .
with a fragment of the pUL9 plasmid (Cross 1997 promoter (Gari et al. 1997) .
LacZ fusions and ␤-gal assays: The lacZ fusions used in this genes, blocking the pathways responsible for AICAR study have been previously described (Daignan-Fornier and biosynthesis. Together these data suggest a more gen- Fink 1992; Guetsova et al. 1997) . P115 is a plasmid carrying eral role for AICAR than first thought.
an ADE1-lacZ fusion in the 2 URA3 vector YEp356R (Myers Because AICAR is at the crossroads between several et al. 1986). P473 is a plasmid carrying an ADE1-lacZ fusion in pathways, it is crucial to fully understand its function in a 2 LEU2 vector YEp367 (Myers et al. 1986 ). ␤-Gal assays were performed as described by Kippert (1995) sion and we identify the pathways responsible for AICAR
In each experiment, at least two independent ␤-gal assays were synthesis. Moreover, we show that deregulation of the performed, and each assay was done on three independent histidine pathway can affect the IMP biosynthesis pathtransformants. The variation between assays in each experiment was Ͻ20%.
way, thus providing an explanation for histidine-purine 
Adenylosuccinate lyase assay: Adenylosuccinate lyase activity vation of ADE gene expression. However, the role of was measured as previously described (Guetsova et al. 1997) .
AICAR in the regulation of the ADE genes remains to be Northern blot: Northern blot experiments were made as elucidated. Indeed, AICAR accumulation in the ade16 previously described (Pinson et al. 2001) .
ade17 double mutant could lead to activation of the ADE genes either directly or indirectly through "retrosynthesis" of SAICAR or feedback inhibition of Ade13p.
RESULTS
To discriminate between these possibilities, we used the Both AICAR and SAICAR can activate expression of cells to synthesize AICAR from the histidine pathway. the ADE genes: As mentioned in the Introduction,
In an ade8 ade16 ade17 triple mutant, ADE1-lacZ expression was only slightly lower than that in the ade16 ade17 SAICAR accumulation is clearly correlated with the acti-ure 1). To our surprise, ADE1-lacZ was still expressed in ade3 his1 and ade3 his7 ( Figure 4A ) mutant strains, although at a lower level than in an ade3 single mutant. This result indicated that AICAR produced through histidine biosynthesis indeed affected expression of the ADE1-lacZ fusion, but, intriguingly, it also suggested that AICAR can be produced even when both the histidine and the IMP pathways are blocked. However, there is no direct evidence that the ade3 mutation leads to a total block of the Ade8p catalyzed step. We therefore fact that in an ade3 ade5,7 his1 triple mutant, when both the histidine and the IMP pathways are blocked, the expression of ADE1-lacZ was almost undetectable (Figdouble mutant (Figure 2 ), indicating that AICAR proure 4C). Furthermore, similar results were obtained vided by the histidine pathway appeared sufficient to when expression of the ADE17 gene was assayed by activate ADE gene expression. Expression of ADE1-lacZ Northern blot in the different mutant strains (Figure was also high in an ade3 mutant that is unable to synthe-4D). Importantly, we found that ADE1-lacZ expression size 10-formyl-THF, a cosubstrate used in the reactions in low-adenine medium was the same in ade3 ade5,7 his1 catalyzed by Ade8p and Ade16p Ade17p (Figure 2) . and ade3 ade8 his1 triple mutants (data not shown), Therefore, since the triple ade8 ade16 ade17 mutant thus establishing that the leakage observed in the ade3 phenocopies the single ade3 mutant, the ade3 mutant mutant is due to residual Ade8p activity in the absence was used in the rest of the study.
of 10-formyl-THF synthesized by Ade3p. Therefore, our We then monitored expression of ADE1-lacZ in an results show that both the histidine and the IMP pathade2 ade3 ade13 triple-mutant strain. In such a strain, ways significantly contribute to AICAR accumulation in AICAR synthesized from the histidine pathway can accuyeast. mulate (see previous section), while SAICAR cannot be Deregulation of the histidine biosynthesis pathway produced through either normal synthesis or "retroimpairs regulation of AMP biosynthesis: Since AICAR synthesis" from AICAR, because of the ade2 and ade13 contributes to expression of ADE genes and can be promutations, respectively (Figure 1 ). An ade2 ade13 douvided through the histidine biosynthesis pathway, we ble mutant was mated to an ade3 mutant and expression evaluated the role of the histidine biosynthesis pathway of ADE1-lacZ was measured in the parental strains (Fig- in the regulation of AMP biosynthesis. This was done ure 3A) and in the meiotic progeny ( Figure 3B ). Expresby using mutants either decreasing or increasing the sion of ADE1-lacZ was high in the ade3 ade13 and ade2 flux in the histidine pathway. ade3 double mutants as well as in the two triple ade2
Deletion of any of the HIS genes had no effect on the ade3 ade13 mutant spores that can accumulate AICAR expression of the ADE1-lacZ fusion (data not shown). but not SAICAR ( Figure 3B ). Consistently, Northern
This result indicates that AICAR synthesis from the histiblot analyses revealed that expression of another ADE dine biosynthesis pathway is not required for full inducgene, ADE17, was high in the ade2 ade3 ade13 mutant tion of the AMP biosynthesis pathway in the absence of ( Figure 3C ). These two results establish that AICAR, adenine. like SAICAR, can directly activate expression of the ADE To stimulate the histidine pathway, we used a gcd2 genes. mutant known to deregulate HIS gene transcription Genetic analysis reveals the role of histidine and IMP (Hinnebusch 1988) . GCD2 encodes a protein that negapathways in AICAR synthesis: As shown in the previous tively regulates synthesis of Gcn4p, a major transcription section, in an ade8 ade16 ade17 or in an ade3 mutant, a activator of HIS genes (Hinnebusch 1988) . Expression significant amount of AICAR can be provided through of ADE1-lacZ was measured in gcd2 and GCD2 isogenic an alternative pathway, most probably the histidine strains in the presence or absence of adenine. The ratio pathway.
of ADE1-lacZ activity under derepression (no adenine) To further evaluate the cellular supply routes for and repression (with adenine) defines the adenine re-AICAR, we constructed ade3 his1 and ade3 his7 doublepression factor. This repression factor was significantly mutant strains in which both the IMP and histidine lower in the gcd2 mutant (7.8 Ϯ 0.8) than in the wildtype strain (15.1 Ϯ 1.7). As expected, this difference was pathways are blocked upstream of AICAR synthesis (Fig-Purine- 
Strains Y16591 (ade3) and Y1261 (ade2 ade13) were mated and after sporulation of the resulting diploid, tetrads were isolated. (A and B) The parental strains and the spores of two tetrads were transformed with a plasmid carrying the ADE1-lacZ fusion (P115) and grown for 6 hr in SD casa medium containing adenine at either low (0.025 mm) or high (0.3 mm) concentration. ␤-Gal activity was then measured as described in materials and methods. Strains were (A) parental strains Y1261 (ade2 ade13) and Y16591 (ade3); and (B) meiotic progeny strains Y1975 (wild type), Y1976 (ade2 ade3), Y1977 (ade2 ade3 ade13), Y1978 (ade13), Y1979 (ade2), Y1980 (ade3 ade13), Y1981 (ade2 ade3 ade13), and Y1982 (wild type). (C) Northern blot analysis of ADE17 gene expression in the ade2 ade3 ade13 mutant strain. Strains Y1975 (wild type), Y1261 (ade2 ade13), Y1980 (ade3 ade13), Y1976 (ade2 ade3), and Y1977 (ade2 ade3 ade13) were grown to an OD 600 of 0.5 in SD casa medium with or without adenine as indicated. Extraction of RNA and hybridization were performed as described in materials and methods. Radioactivity was detected using a Phosphorimager and signal was quantified using the ImageQuant software. The quantification is presented as the ADE17/ACT1 ratio, which was arbitrarily set up as "1" in the wild-type "ϩade" control lane.
abolished when the same strains were grown in the simple hypothesis to account for this phenotype is that AICAR inhibits one of the histidine biosynthesis pathway absence of histidine. This result indicates that the activation of the histidine pathway in the presence of adenine enzymes. We reasoned that, conversely, overexpression of the inhibited enzyme might partially overcome this results in partial derepression of the ADE1-lacZ expression. This was confirmed by monitoring ADE1-lacZ exinhibition and result in bradytrophy for histidine. We therefore individually expressed the HIS genes in the pression in the HIS1-17 dominant mutant that is not feedback inhibited by histidine (Rasse-Messenguy and ade3 and ade16 ade17 mutant strains and monitored growth of these strains in the presence or absence of Fink 1973) and consequently overproduces histidine, which is excreted in the medium. The HIS1-17 mutant histidine. None of these constructs was sufficient to restore histidine prototrophy while all the constructs comwas mated to a wild-type strain and, after sporulation and tetrad dissection, the ADE1-lacZ plasmid was introduced plemented the cognate his mutation (data not shown).
Since we did not succeed in constructing a plasmid overinto 88 spores (22 tetrads). Expression of the fusion measured in the presence or absence of adenine reexpressing HIS1, we took advantage of the dominant HIS1-17 mutant, which leads to overproduction and exvealed a clear cosegregation between the HIS1-17 allele (monitored by excretion of histidine) and a lower factor cretion of histidine (Rasse-Messenguy and Fink 1973). The ade3 HIS1-17 double mutant was still auxotrophic of repression by adenine: the repression factor in wildtype strains was 16.0 Ϯ 5.0, while it was 5.2 Ϯ 2.5 in for histidine and could no longer excrete histidine, indicating that the HIS pathway is still blocked in this mutant HIS1-17 mutant strains. These results establish that, in the presence of adenine, a constitutively active histidine (data not shown). Importantly, our results in the previous sections clearly show that, in an ade3 ade5,7 double biosynthesis pathway can lead to a partial deregulation of AMP biosynthesis. In both gcd2 and HIS1-17, expresmutant, AICAR can be synthesized only from the histidine pathway, and in such a mutant, ADE1-lacZ expression of the fusion was affected only in high-adenine medium while expression levels in low-adenine medium sion was still activated. This result indicates that the early steps of histidine biosynthesis required for AICAR were similar.
Auxotrophy for histidine of ade3 and ade16 ade17 production are still functional in the ade3 ade5,7 double mutant and therefore are unlikely targets for inhibition mutant strains cannot be simply suppressed by overexpression of HIS genes or by mutations in the folate by AICAR. The inhibition by AICAR is thus rather likely to affect one (or several) of the last four steps of the interconversion pathway: Intriguingly, both ade3 and ade16 ade17 mutant strains are auxotrophic for histidine.
pathway. The last step, catalyzed by histidinol dehydrogenase, allows synthesis of histidine from histidinol. HisBecause these two strains are blocked in the ninth step of IMP biosynthesis, we thought that this auxotrophy tidinol cannot be taken up by wild-type yeast cells, but a HOL1-1,101 dominant allele of the HOL1 gene was was likely to be due to an accumulation of AICAR. A ade17 strains allowed growth on histidinol, showing that histidinol dehydrogenase is not inhibited in these strains (data not shown). Therefore, the inhibition of AICAR should affect one of the three remaining late steps catalyzed by His3p, His5p, and His2p (Figure 1) . However, overexpression of these three genes in the same strain was not sufficient to suppress the auxotrophy for histidine (data not shown).
Since accumulation of AICAR was shown to interfere with folate and methionine biosynthesis (Holmes and Appling 2002) , we thought that the AICAR effect on the histidine pathway could indirectly be due to accumulation of an intermediate in the methionine or folate pathways. We therefore tried to suppress the His Ϫ phenotype of ade3 by combining ade3 with mutations of these two pathways ( Figure 5) .
The ade3 fau1 double mutants had a severe growth defect even on rich medium ( Figure 6A ) and were auxotrophic for methionine ( Figure 6B ) as reported for the triple ade16 ade17 fau1 mutant (Holmes and Appling 2002) . Therefore, this result further shows that ade3 phenocopies an ade16 ade17 mutant. We observed that the ade3 fau1 methionine auxotrophy was much tighter at 30Њ than at 25Њ ( Figure 6B ).
Combining ade3 with mtd1, met6, met12, or met13 did not result in any synthetic phenotype (data not shown). However, we found a clear synthetic lethality between ade3 and shm2 as suggested by multiple incomplete tetrads ( Figure 6C ) and confirmed by further genetics analysis (data not shown). Such a synthetic lethality had been previously reported by others (Nigavekar and Cannon 2002) although ade3 shm2 double mutants appear viable in other backgrounds (McNeil et al. 1996) . Finally, ade3 shm1 double mutants were perfectly viable previously published results (Koren et al. 2003) . Impor-(A-C). Yeast strains transformed with a plasmid carrying the tantly, none of these double mutants were prototrophic ADE1-lacZ fusion (P115) were grown for 6 hr in SD casa medium containing adenine at either low (0.025 mm) or high for histidine (data not shown).
(0.3 mm) concentration. ␤-Gal activity was then measured Finally, since AICAR is thought to affect the interacas described in materials and methods. Strains were: (A) tion between the transcription factors Bas1p and Bas2p, BY4742 (wild type), Y16591 (ade3), Y10190 (his1), Y13388
we wondered whether the histidine auxotrophy would which is likely to result from AICAR accumulation, is Y10190 (his1), Y14601 (ade5,7), Y16591 (ade3), Y1166 (ade3 independent of the effect of AICAR on Bas1p or Bas2p.
his1), Y1551 (ade3 ade5,7), and Y1657 (ade3 ade5,7 his1) were grown to an OD 600 of 0.5 in SD casa medium with or without
Overexpression of PMU1 partially bypasses histidine adenine as indicated. Extraction of RNA and hybridization auxotrophy of an ade3 ade16 ade17 mutant by detoxifywere performed as described in materials and methods.
ing AICAR: A search for multicopy suppressors of histiRadioactivity was detected using a phosphorimager and signal dine auxotrophy of an ade3 ade16 ade17 triple mutant was quantified using the ImageQuant software. The quantifiallowed us to identify five plasmids carrying a 3-kb DNA cation is presented as the ADE17/ACT1 ratio, which was arbitrarily set up as "1" in the wild-type "ϩade" control lane.
fragment from chromosome XI that could clearly restore histidine prototrophy to the triple mutant ( Figure  7A ). Subcloning experiments revealed that PMU1, enshown to allow utilization of histidinol as a histidine source (Gaber et al. 1990) . Introduction of the HOL1-coding a potential phosphomutase, was responsible for the suppression ( Figure 7B) . A simple hypothesis would 1,101 allele carried on a plasmid in the ade3 and ade16 be that overexpression of PMU1 bypasses histidine auxassociated with histidine auxotrophy since ade13 mutants are prototrophic for histidine biosynthesis. otrophy by replacing the impaired activity in the late histidine pathway. Clearly, overexpression of PMU1 in his2, his3, or his5 mutants could not suppress histidine DISCUSSION auxotrophy (data not shown). We therefore hypothesized that PMU1 directly affects AICAR, which is thought Both AICAR and SAICAR activate expression of ADE genes: In this article, we establish that AICAR can actito be responsible for the inhibition of a late step of histidine biosynthesis. Indeed, because it encodes a povate expression of ADE genes, as reported previously for another purine metabolic intermediate, SAICAR tential phosphomutase, PMU1 could simply transform AICAR into another derivative with lower inhibitory abil- (Rébora et al. 2001) . AICAR is produced through the IMP biosynthesis pathway, but also by His7p during histiity. To test this hypothesis, we took advantage of the fact that overproduction of AICAR is toxic for yeast cells. dine biosynthesis. However, mutations in the first steps of IMP synthesis, upstream of AICAR synthesis, result The IMP biosynthesis pathway was made constitutively active by overexpressing the ADE4 gene (Rébora et al. in complete adenine auxotrophy, indicating that AICAR synthesis from the histidine pathway cannot provide 2001) in various ade mutant strains. The overexpression of ADE4 strongly affected growth of an ade16 ade17 dousufficient synthesis of purine nucleotides for cell growth in the absence of extracellular adenine. This is not surble-mutant strain whereas it had no effect on the ade16 or ade17 single-mutant strains ( Figure 7C ). This result prising since AICAR provided by the histidine pathway is produced at the cost of one ATP molecule (Figure strongly suggests that AICAR overproduction is toxic for yeast cells. Consistently, overexpression of ADE4 had 1) and is then recycled through the AMP biosynthesis pathway. Therefore, AICAR produced during histidine no toxic effect on ade3 or ade8 ade16 ade17 mutant strains ( Figure 7C ), which are blocked upstream in the pathway biosynthesis does not contribute to net AMP de novo synthesis. and are therefore insensitive to overexpression of ADE4. Further, concomitant overexpression of ADE4 and However, we observed that AICAR produced during histidine biosynthesis can affect the regulation of AMP PMU1 resulted in improved growth ( Figure 7D ), indicating that PMU1 could partially bypass the negative effect biosynthesis in the presence of adenine under certain circumstances. Indeed, while a block in the histidine of AICAR accumulation. We therefore believe that PMU1 suppresses histidine auxotrophy by somehow depathway had no effect on ADE1-lacZ expression, either transcriptional or enzymatic deregulation of histidine toxifying AICAR.
Importantly, accumulation of SAICAR also appears biosynthesis resulted in a partial derepression of ADE1-lacZ. This result clearly justifies the coregulation of HIS1, toxic since we found that overexpression of ADE4 strongly affected growth of various ade13 mutant strains HIS4, and HIS7 genes with ADE genes. Indeed, in the presence of extracellular adenine, expression of ADE ( Figure 7E) . Consistently, the growth defect was strongly correlated with the strength of the ade13 allele, estigenes should be turned off and the level of AICAR and SAICAR (which are required as coactivators of ADE gene mated by direct measurement of residual adenylosuccinate lyase activity in the mutant strains ( Figure 7E ). transcription) should be kept as low as possible. The observed repression of early steps of histidine biosyntheThus toxicity appears to be correlated with the amount of SAICAR accumulated. However, it should be noted sis by adenine is most probably necessary to avoid unwanted expression of ADE genes due to the synthesis of that while both AICAR and SAICAR accumulation appear toxic for yeast cells, only AICAR accumulation is AICAR by the histidine pathway.
Johnston 1980) . No such phenotype was associated with the HIS1-17 yeast mutation (K. Rébora and B. Daignan-Fornier, unpublished observations), which suggests that the respective flux in the IMP and histidine pathways differs in yeast and bacteria. Furthermore, while similar ATP depletion was observed in both ade3 and ade3 ade5,7 his1 mutants grown in low-adenine medium (down to 10% of wild-type level; B. Laloo and B. Daignan-Fornier, unpublished observations), expression of ADE1-lacZ was high in the former and low in the latter. These results further confirm that AICAR synthesis is critical for transcriptional activation of ADE genes in the absence of adenine. However, it should be kept in mind that, in the presence of adenine, ATP has an important inhibitory effect on the first enzyme of the pathway, Ade4p (Rébora et al. 2001) .
What is the role of AICAR accumulation in producing auxotrophy for histidine of the ade3 and ade16 ade17 mutant strains? ade3 and ade16 ade17 mutant strains are the only mutants of the AMP biosynthesis pathway that are auxotrophic for both adenine and histidine. Since these mutants cannot metabolize AICAR and are therefore likely to accumulate this metabolite, it was proposed by Appling and co-workers that AICAR accumulation was responsible for histidine auxotrophy, possibly by inhibiting an enzyme of the histidine pathway (Tibbetts and Appling 2000). However, we found that neither a constitutive HIS1 dominant allele nor the overexpression of any of the HIS2-HIS7 genes is able to suppress the requirement for histidine of an ade3 or ade16 ade17 mutant strain. Together these results suggest that the histidine auxotrophy of ade3 and ade16 pathway, but rather takes place via a more complex can detoxify AICAR and suppress histidine auxotrophy of the ade3 ade16 ade17 triple mutant. This result further correlates AICAR accumulation and histidine auxotrophy in these mutants. The mechanism by which Pmu1p Additionally, the histidine pathway could affect IMP acts on AICAR is not clear, but since PMU1 encodes a biosynthesis regulation by depleting the adenylate pool.
potential phosphomutase, it presumably could directly Indeed, such an ATP depletion due to deregulation of modify AICAR, which is a monophosphate nucleotide histidine synthesis has been extensively documented in derivative. Consistently, PMU1 was previously isolated bacteria and it has been shown that hisG deregulated as a multicopy suppressor of the temperature sensitivity mutants lead to adenine auxotrophy in Escherichia coli and Salmonella (Shedlovsky and Magasanik 1962a,b;  of a tps2 mutant lacking trehalose-phosphatase activity Strains were transformed with either a control plasmid (pCM189, vector) or a plasmid expressing the tet-ADE4 fusion (P1933, tet-ADE4). A serial dilution of the different transformants was dropped onto SD casa medium supplemented with adenine and tryptophan, and growth of cells was observed after 3 days at 30Њ. The following strains were used: Y1095 (ade16 ade17), BY4742 (wild type), Y11583 (ade16), Y16561 (ade17), Y16591 (ade3), and Y1164 (ade3 ade16 ade17). (D) Effect of overexpression of PMU1 on AICAR toxicity. A serial dilution of the Y1095 (ade16 ade17) strain transformed with tet-ADE4 (P2122) and either PMU1 overexpressing plasmids or the control vector was dropped onto SC medium with or without tetracycline as indicated. Growth of cells was observed after 3 days at 30Њ. (E) Toxicity of SAICAR accumulated in ade13 mutant strains. The following strains were used: PLY122 (wild type), 206 (ade13-52), 211 (ade13-23), and 242 (ade13-42). Residual adenylosuccinate lyase activity was measured in the four strains as described in materials and methods and indicated as a percentage of wild-type activity. Growth of cells was observed after 3 days at 30Њ. and shown to reduce the accumulation of trehalosedation and autistic features. Several mutations that lead to ASL deficiency have been reported. The mutated 6-phosphate in this mutant (Elliott et al. 1996) .
Toxicity of AICAR and SAICAR accumulation: In the enzymes showed different levels of residual enzymatic activity that are correlated to different degrees of mental course of this work we found that accumulation of SAICAR and AICAR can be toxic for yeast. The toxicity retardation (Race et al. 2000) . The link between SAICAriboside and succinyladenosine accumulation and is detected only when the pathway is made constitutive by overexpressing Ade4p, the first enzyme of the pathneurological abnormalities is not understood yet and future studies on SAICAR toxicity could provide imporway. This effect is clearly due to overproduction of AICAR (or SAICAR) from the IMP de novo pathway since tant clues. Strikingly, accumulation of AICAR derivatives due to a mutation in AICAR transformylase (the equivamutations upstream in the pathway totally abolish the toxicity. In vitro AICAR can activate mammalian AMPlent of yeast Ade16p Ade17p activity; see Figure 1 ) was recently found to be associated with severe neurological activated protein kinase (AMPK) (Sullivan et al. 1994; Corton et al. 1995; Stefanelli et al. 1998), and theredefects (Marie et al. 2004) . Therefore, accumulation of AICAR and SAICAR is clearly deleterious for humans. fore AICAR toxicity could at least partly result from incorrect regulation of AMPK due to accumulation of In the future, yeast genetics could certainly prove useful in investigating the molecular mechanisms leading to the metabolite. However, the effect of AICAR on Snf1p, the yeast equivalent of AMPK, has not yet been docuthis toxicity.
Our results, together with previous data in yeast and mented.
Interestingly, adenylosuccinate lyase (ASL, the equivother organisms, strongly suggest that AICAR and SAICAR interfere with histidine and methionine synthealent of yeast Ade13p; see Figure 1 ) deficiency in humans is characterized by accumulation in body fluids sis pathways and other cellular processes. Clearly, these two intermediary metabolites are not just inert moleof SAICAriboside and succinyladenosine, the two dephosphorylated derivatives of SAICAR and adenylosuccules "waiting" for further metabolizing to IMP but are involved in regulatory crosstalks. Because their concencinate, which are the substrates of ASL ( Jaeken and Van den Berghe 1984) . ASL deficiency leads to varying tration reflects the flux in the AMP biosynthesis pathway, these small molecules are informative and could degrees of neurological abnormalities, i.e., mental retar-
